buprenorphine - Addiction Technology Transfer Center (ATTC) Network

The opinions expressed herein are the views of the authors and do not reflect the official position of the Department of Health and Human Services (DHHS), SAMHSA, CSAT or the ATTC Network. No official support or endorsement of DHHS, SAMHSA, or CSAT for the opinions of authors presented in this e-publication is intended or should be inferred.

Tag: buprenorphine

AMERSA People & Passion, Episode 3: Barriers to Treatment for Opioid Use Disorder: Why Aren’t Pharmacists Stocking Buprenorphine?

Published: 09/22/2021

Patients with opioid use disorder must be able to obtain prescribed buprenorphine from a pharmacy promptly to reduce risk for a recurrence of use and subsequent morbidity and mortality. However, phone-based secret shopper surveys indicate many pharmacies do not consistently maintain an adequate stock of buprenorphine and qualitative surveys show some pharmacists refuse to dispense […]

The Treatment Challenge in Jail Settings: Detox and Withdrawal or Continuing Medication?

Published: 06/30/2021

Jessica Vechinski, MSWProject Manager, Justice Community Opioid Innovation Network (JCOIN)Center for Health Enhancement Systems Studies, UW-Madison Opioid use disorder (OUD) is prevalent among people in the criminal justice system—estimates show that as many as 50–65 percent of people entering the system have an OUD or other substance use disorder (SUD). Yet, access to high-quality treatment […]

Opioid Treatment and Recovery News Roundup

Published: 07/12/2018

July 12, 2018 Maureen Fitzgerald ATTC Network/NIATx Have you been taking a summer break from the news? Get caught up with five recent news and research headlines, plus a great new Road to Recovery TV episode from SAMHSA: 1. Expanding primary care buprenorphine treatment could curb opioid overdose crisis Science Daily Research published by Drs. Sarah Wakeman and […]